NJ State Employees Deferred Compensation Plan’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,900
| Closed | -$54.4K | – | 462 |
|
|
2024
Q4 | $54.4K | Hold |
17,900
| – | – | 0.01% | 454 |
|
|
2024
Q3 | $92.9K | Hold |
17,900
| – | – | 0.01% | 457 |
|
|
2024
Q2 | $46K | Hold |
17,900
| – | – | 0.01% | 461 |
|
|
2024
Q1 | $88.1K | Hold |
17,900
| – | – | 0.01% | 459 |
|
|
2023
Q4 | $157K | Hold |
17,900
| – | – | 0.02% | 452 |
|
|
2023
Q3 | $205K | Hold |
17,900
| – | – | 0.03% | 425 |
|
|
2023
Q2 | $453K | Hold |
17,900
| – | – | 0.07% | 296 |
|
|
2023
Q1 | $577K | Hold |
17,900
| – | – | 0.09% | 243 |
|
|
2022
Q4 | $330K | Hold |
17,900
| – | – | 0.05% | 349 |
|
|
2022
Q3 | $483K | Buy |
+17,900
| New | +$483K | 0.08% | 251 |
|